|
Symbol Name ID |
Sgms2
sphingomyelin synthase 2 MGI:1921692 |
| * | Aspects of the system are reported to show a normal phenotype. |
| Darker colors indicate more annotations |
| Human Phenotypes | Elevated circulating alkaline phosphatase concentration |
| Disease(s) Associated with SGMS2 | |
| calvarial doughnut lesions with bone fragility |
| Mouse Phenotypes | homeostasis/metabolism phenotype |
decreased susceptibility to diet-induced obesity |
abnormal circulating glucose level |
increased circulating free fatty acids level |
decreased circulating triglyceride level |
abnormal circulating protein level |
improved glucose tolerance |
increased insulin sensitivity |
abnormal lipid level |
abnormal sphingomyelin level |
abnormal ceramide level |
|
| Availability | Mouse Genotype | |||||||||||
| Sgms2tm1Jia/Sgms2tm1Jia | * | |||||||||||
| Sgms2tm1Kenw/Sgms2tm1Kenw | ||||||||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|
|
||
Analysis Tools